Clinical Trials Directory

Trials / Terminated

TerminatedNCT01755702

Paracetamol With Caffeine to Treat Episodic Tension Type Headache

A Study to Assess the Efficacy of Paracetamol Taken in Combination With Caffeine for the Treatment of Episodic Tension Type Headache

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
66 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will compare a fast-absorbing paracetamol plus caffeine formula with placebo and an over-the-counter dose of paracetamol and ibuprofen to treat episodic tension headache.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboPlacebo
DRUGExperimental paracetamol + caffeine formulationexperimental paracetamol + caffeine formulation
DRUGibuprofen marketed formulationibuprofen marketed formulation
DRUGParacetamol marketed formulationParacetamol marketed formulation

Timeline

Start date
2009-07-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2012-12-24
Last updated
2015-03-27
Results posted
2015-03-27

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01755702. Inclusion in this directory is not an endorsement.